Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
25
0.610
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
994
0.530
 Why?
Leukemia, Myeloid, Acute
4
2010
186
0.420
 Why?
Osteosarcoma
2
2016
47
0.340
 Why?
von Willebrand Diseases
1
2009
22
0.330
 Why?
Hematology
1
2009
24
0.330
 Why?
Sclerotherapy
2
2020
46
0.330
 Why?
Antineoplastic Agents
5
2016
1186
0.300
 Why?
Vascular Malformations
2
2020
99
0.290
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.290
 Why?
Hemophilia B
1
2007
4
0.290
 Why?
Hemostasis, Surgical
1
2007
12
0.290
 Why?
Blood Coagulation Factors
1
2007
17
0.290
 Why?
Enoxaparin
1
2007
27
0.280
 Why?
Child, Preschool
13
2020
3877
0.280
 Why?
Blood Loss, Surgical
1
2007
72
0.280
 Why?
Venous Thrombosis
1
2007
90
0.260
 Why?
Cisplatin
3
2016
277
0.260
 Why?
Cyclosporine
1
2005
65
0.250
 Why?
Blood Coagulation Disorders
2
2020
38
0.250
 Why?
Leukemia
1
2005
65
0.250
 Why?
Hemostasis
2
2020
56
0.250
 Why?
Cladribine
1
2004
3
0.240
 Why?
Bone Regeneration
2
2016
70
0.240
 Why?
Histiocytosis, Langerhans-Cell
1
2004
27
0.230
 Why?
Retinal Neoplasms
1
2003
13
0.220
 Why?
Retinoblastoma
1
2003
16
0.220
 Why?
Infant
11
2018
3560
0.220
 Why?
Neoplasms
3
2012
1250
0.210
 Why?
Neoplasms, Second Primary
1
2003
78
0.210
 Why?
Child
14
2020
6854
0.200
 Why?
Bone Neoplasms
1
2003
183
0.190
 Why?
Thrombelastography
1
2020
24
0.180
 Why?
Adolescent
11
2020
6402
0.180
 Why?
Bleomycin
1
2018
35
0.150
 Why?
Down Syndrome
3
2008
89
0.150
 Why?
Antibiotics, Antineoplastic
1
2018
80
0.140
 Why?
Osteogenesis, Distraction
2
2016
78
0.140
 Why?
Piperazines
2
2016
118
0.140
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
6
0.140
 Why?
Leukemia, Myeloid
2
2008
43
0.130
 Why?
Humans
21
2020
50251
0.130
 Why?
Disease-Free Survival
5
2010
454
0.130
 Why?
Male
13
2020
25483
0.130
 Why?
Remission Induction
4
2011
207
0.120
 Why?
Imidazoles
1
2016
128
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
92
0.120
 Why?
Leukocyte Count
2
2005
72
0.110
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
40
0.110
 Why?
Survival Analysis
4
2010
666
0.110
 Why?
Doxorubicin
2
2005
238
0.110
 Why?
Cord Blood Stem Cell Transplantation
1
2011
5
0.100
 Why?
Sarcoma, Myeloid
1
2011
20
0.100
 Why?
Neutropenia
1
2012
115
0.100
 Why?
Heart Neoplasms
1
2011
33
0.100
 Why?
Treatment Outcome
7
2018
5186
0.090
 Why?
Core Binding Factors
1
2010
2
0.090
 Why?
Proto-Oncogene Proteins c-kit
1
2010
36
0.090
 Why?
Female
10
2020
26668
0.080
 Why?
Entamoebiasis
1
2009
2
0.080
 Why?
Diarrhea, Infantile
1
2009
5
0.080
 Why?
Listeriosis
1
2009
7
0.080
 Why?
Liver Abscess
1
2009
5
0.080
 Why?
Anemia, Aplastic
1
2009
12
0.080
 Why?
Platelet Transfusion
1
2009
28
0.080
 Why?
Histocompatibility Testing
1
2008
12
0.080
 Why?
Acute Lung Injury
1
2009
25
0.080
 Why?
Young Adult
5
2020
4002
0.080
 Why?
HLA Antigens
1
2008
53
0.080
 Why?
Abdominal Pain
1
2009
83
0.080
 Why?
Bone Marrow Transplantation
1
2008
116
0.080
 Why?
Hospitals, Pediatric
1
2009
234
0.080
 Why?
Retrospective Studies
6
2018
6172
0.080
 Why?
Adult
7
2020
13384
0.070
 Why?
Infusions, Intravenous
2
2004
214
0.070
 Why?
Cardiomyopathies
1
2008
116
0.070
 Why?
Mitolactol
1
2005
2
0.070
 Why?
GATA1 Transcription Factor
1
2005
7
0.070
 Why?
Karyotyping
1
2005
83
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2006
828
0.060
 Why?
Tamoxifen
1
2005
60
0.060
 Why?
Heart
1
2008
331
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
51
0.060
 Why?
Immunosuppressive Agents
1
2005
223
0.060
 Why?
Proto-Oncogene Proteins
1
2004
149
0.060
 Why?
Humerus
1
2003
18
0.060
 Why?
Arkansas
1
2009
1962
0.060
 Why?
Tibia
1
2003
116
0.050
 Why?
Mutation
2
2010
1296
0.050
 Why?
Methotrexate
1
2003
71
0.050
 Why?
Survivors
1
2003
120
0.050
 Why?
Topotecan
1
2002
17
0.050
 Why?
Automation
1
2002
17
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
391
0.050
 Why?
Blood Coagulation Tests
1
2020
19
0.050
 Why?
Dose-Response Relationship, Drug
1
2004
1377
0.050
 Why?
Blood Flow Velocity
1
2020
101
0.050
 Why?
Blood Coagulation
1
2020
58
0.040
 Why?
Follow-Up Studies
2
2018
2180
0.040
 Why?
Prognosis
3
2012
1959
0.040
 Why?
Gene Expression Profiling
1
2004
1041
0.040
 Why?
Mice, Inbred C57BL
2
2016
1823
0.040
 Why?
Hemorrhage
1
2020
197
0.040
 Why?
Daunorubicin
2
2008
12
0.040
 Why?
Cytarabine
2
2006
39
0.030
 Why?
Mice, Nude
1
2016
254
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
213
0.030
 Why?
Random Allocation
1
2016
287
0.030
 Why?
Acute Disease
2
2008
368
0.030
 Why?
Cluster Analysis
2
2005
235
0.030
 Why?
Prospective Studies
2
2012
2379
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
412
0.030
 Why?
Interleukin-3
1
2012
13
0.030
 Why?
Calcitonin Gene-Related Peptide
1
2012
22
0.030
 Why?
Protein Precursors
1
2012
43
0.030
 Why?
Calcitonin
1
2012
30
0.030
 Why?
Sensitivity and Specificity
2
2006
869
0.020
 Why?
Interleukin-8
1
2012
86
0.020
 Why?
Interleukin-10
1
2012
84
0.020
 Why?
ROC Curve
1
2012
233
0.020
 Why?
Fatal Outcome
1
2011
196
0.020
 Why?
Mice, Knockout
1
2013
847
0.020
 Why?
Interleukin-6
1
2012
267
0.020
 Why?
Intensive Care Units
1
2012
222
0.020
 Why?
Exons
1
2010
95
0.020
 Why?
Pilot Projects
1
2012
704
0.020
 Why?
Animals
2
2016
13285
0.020
 Why?
Time Factors
2
2008
2911
0.020
 Why?
Opportunistic Infections
1
2009
58
0.020
 Why?
Echocardiography
1
2011
373
0.020
 Why?
Mitoxantrone
1
2008
9
0.020
 Why?
Translocation, Genetic
1
2010
264
0.020
 Why?
Hospitalization
1
2012
663
0.020
 Why?
Proportional Hazards Models
1
2008
407
0.020
 Why?
Recurrence
1
2008
661
0.020
 Why?
Genetic Predisposition to Disease
1
2010
507
0.020
 Why?
Prevalence
1
2010
953
0.020
 Why?
Immunophenotyping
1
2006
110
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1169
0.020
 Why?
Nucleic Acid Hybridization
1
2005
54
0.020
 Why?
Luciferases
1
2005
50
0.020
 Why?
Middle Aged
1
2020
12234
0.020
 Why?
Cell Membrane
1
2006
253
0.020
 Why?
DNA Primers
1
2005
207
0.020
 Why?
Diagnosis, Differential
1
2009
1043
0.020
 Why?
Transfection
1
2005
355
0.020
 Why?
Tumor Cells, Cultured
1
2005
468
0.020
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.020
 Why?
fms-Like Tyrosine Kinase 3
1
2004
16
0.010
 Why?
Magnetic Resonance Imaging
1
2011
1542
0.010
 Why?
Benzamides
1
2004
51
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
594
0.010
 Why?
Risk Assessment
1
2008
1257
0.010
 Why?
Risk Factors
1
2012
3608
0.010
 Why?
Mice
1
2013
5770
0.010
 Why?
Pyrimidines
1
2004
194
0.010
 Why?
Nuclear Proteins
1
2004
243
0.010
 Why?
DNA Helicases
1
2004
144
0.010
 Why?
Predictive Value of Tests
1
2004
914
0.010
 Why?
DNA-Binding Proteins
1
2004
428
0.010
 Why?
Linear Models
1
2002
276
0.010
 Why?
Drug Administration Schedule
1
2002
374
0.010
 Why?
Neutrophils
1
2002
147
0.010
 Why?
Analysis of Variance
1
2002
563
0.010
 Why?
Transcription Factors
1
2004
564
0.010
 Why?
Patient Selection
1
2002
252
0.010
 Why?
Infant, Newborn
1
2006
2767
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (167) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department